Expert Ratings for AVITA Medical
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for AVITA Medical (NASDAQ:RCEL) in the last quarter, with an average price target of $25.6, a high of $27.00, and a low of $23.00. This average price target has increased by 40.27% over the past month.
October 19, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AVITA Medical has received bullish ratings from analysts, with an average price target of $25.6. This target has increased by 40.27% over the past month.
The bullish ratings and the increase in the average price target over the past month indicate a positive outlook for AVITA Medical. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100